Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

SpringerPlus

Table 3 Additional model outcomes

Strategy	Adverse drug event (%)	Number patients with recurrence (%)	Number of death from recurrence^a
1-NNN	0.0325	0.2677	26,078
2-NNY	0.0318	0.22828	22,186
3-NYN	0.0308	0.24287	23,636
4-NYY	0.0301	0.20509	19,863
5-YNN	0.0422	0.23507	22,905
6-YNY	0.0417	0.19817	19,290
7-YYN	0.0412	0.21193	20,593
8-YYY	0.0396	0.17215	16,705